"A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition tothe Paliperidone Palmitate 3-Month Formulation in Patients with SchizophreniaPreviously Stabilized on the Paliperidone Palmitate 1-Month Formulation"
عنوان الدراسة
"A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition tothe Paliperidone Palmitate 3-Month Formulation in Patients with SchizophreniaPreviously Stabilized on the Paliperidone Palmitate 1-Month Formulation"
داعم الدراسة
Janssen-Cilag International NV
دواء الدراسة
paliperidone
رقم بروتوكول الدراسة
R092670SCH3015
حالة الدراسة
Ongoing
موقع الدراسة
Jeddah psychiatric hospital, Al-Amal Complex for mental health (Dammam)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。